Richardson Financial Services’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.8K Buy
255
+29
+13% +$5.16K 0.03% 296
2026
Q1
$39K Buy
226
+108
+92% +$20K 0.02% 329
2025
Q4
$23.5K Buy
+118
New +$21.4K 0.01% 390

Other funds holding CRL

Richardson Financial Services's CRL Position: Q2 2026 in Review

Richardson Financial Services increased its Charles River Laboratories (CRL) stake by 13% in Q2 2026, buying an estimated $5.16K and bringing the position to 255 shares worth $57.8K. The position accounts for 0.03% of the portfolio, ranked #296.

Richardson Financial Services first reported a position in CRL in Q4 2025 and has held it in 3 quarters since. 366 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Richardson Financial Services held 255 shares of Charles River Laboratories worth $57.8K as of Q2 2026.
  • Richardson Financial Services bought 29 Charles River Laboratories shares in Q2 2026, an estimated $5.16K.
  • Charles River Laboratories made up 0.03% of Richardson Financial Services's portfolio in Q2 2026, its #296 holding.
  • Richardson Financial Services first reported a position in Charles River Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Richardson Financial Services's 13F filing for Q2 2026, filed 10 Aug 2026.